Washington, DC (UroToday.com) In today’s state of the art lecture at the Society of Urologic Oncology meeting, Dr. Lewis Cantley discussed Targeting PI3-Kinase (PI3K) Cancer therapy. He began the discussion with a review of the PI3K pathway. PI3K was discovered in the 1980s when it was found that its production correlated with cell transformation. PI3K was associated with glucose uptake and metabolism, which leads to cell survival and growth. In cancer, loss of PTEN leads to cancer cell survival and
SUO 2015 - Health Services
Dr. Thompson was invited to speak in the first state-of-the-art lecture of the SUO winter meeting and addressed the audience about making a difference for patients with next generation clinical trials in GU oncology. He argued that there are essentially three opportunities to make a difference for our patients.
Washington, DC USA (UroToday.com) Dr. Greenberg Caprice from the University of Wisconsin presented their data and experience on surgical coaching of surgeons for performance improvement In the health services session at the 2015 Society of Urologic Oncology. Dr. Greenberg showed that when surgeons are asked to rate their peer’s surgical technical skills a large variation occurs.
Washington, DC USA (UroToday.com) In this session, Dr. Angela Smith channeled former National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, Farzad Mostashari, noted “patient engagement is the blockbuster drug of the century.” Patient-centered outcomes (PCO) are comprised of four basic tenants: understanding outcomes that matter to patients, considering the benefits versus harms of therapy, including diverse patient populations, and incorporating multiple stakeholder opinions.